SCHEMBL17544331

SCHEMBL17544331

COc1ccc(COc2ccc3oc(-c4cncc(C=O)c4)nc3c2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
UTRN P46939 3/20 0.40
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TP53 P04637 3/20 0.39
HPGD P15428 2/20 0.39
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CETP P11597 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
LMNA P02545 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30402554 1.00 MAPT (0.40) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL30402349 0.89 RAB9A (0.47) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL17544292 0.89 RAB9A (0.47) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL30402947 0.86 ALDH1A1 (0.47) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL17544360 0.86 ALDH1A1 (0.47) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL21814253 0.85 HSD17B10 (0.41) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL17544189 0.85 HSD17B10 (0.44) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL30401743 0.85 HSD17B10 (0.44) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL30402536 0.83 HSD17B10 (0.42) MAPTALDH1A1NPC1RAB9AUTRN
SCHEMBL17544425 0.83 HSD17B10 (0.42) MAPTALDH1A1NPC1RAB9AUTRN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258355-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2025-03-25 US disclosed
CN-116655618-A Probes for imaging huntingtin CHDI基金会股份有限公司 2023-08-29 CN disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
CN-107108534-B Probes for imaging huntingtin CHDI基金会股份有限公司 2023-05-09 CN disclosed
EP-4006016-A2 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2022-06-01 EP disclosed
US-11059836-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2021-07-13 US disclosed
US-11059836-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2021-07-13 US disclosed
US-20200102328-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2020-04-02 US disclosed
US-10479802-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2019-11-19 US disclosed
US-10479802-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2019-11-19 US disclosed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed
EP-3186233-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2017-07-05 EP disclosed
WO-2016033445-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 WO disclosed
WO-2016033445-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 MAPT 8/4885ALDH1A1 3976/4885NPC1 163/4885
US-10479802-B2 Probes for imaging huntingtin protein HTT, HYPK, FABP7 MAPT 7/4885ALDH1A1 3949/4885NPC1 112/4885
US-11059836-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 MAPT 8/4885ALDH1A1 3976/4885NPC1 163/4885
US-20200102328-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 MAPT 8/4885ALDH1A1 3976/4885NPC1 163/4885
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, FABP7 MAPT 7/4885ALDH1A1 3949/4885NPC1 112/4885
US-12258355-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 MAPT 8/4885ALDH1A1 3976/4885NPC1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.